...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Zenith new VP

I am not sure there would be a correlation between good clinical results with zen 3694 and the need to hire . I would speculate that if results were subpar or horrible there wouldn't be a need for  a new VP hire. It is possible that a new hire is required as the results could be excellent and the need for further clinical trials that have been discussed in the past from other webcast

 

this hire does bode well

 

Share
New Message
Please login to post a reply